We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLW icon
601
Clearwater Paper
CLW
$354M
$28K 0.01%
1,365
-4,819
-78% -$116K
MLTX icon
602
MoonLake Immunotherapeutics
MLTX
$1.4B
$28K 0.01%
+4,000
New +$208K
MRVI icon
603
Maravai LifeSciences
MRVI
$861M
$28K 0.01%
10,000
– –
TRU icon
604
TransUnion
TRU
$15.5B
$28K 0.01%
+341
New +$31K
TSLY icon
605
YieldMax TSLA Option Income Strategy ETF
TSLY
$673M
$28K 0.01%
600
– –
BLSH
606
Bullish
BLSH
$4.17B
$28K 0.01%
+454
New +$27.8K
ARBE icon
607
Arbe Robotics
ARBE
$94.2M
$27K 0.01%
16,380
+3,009
+23% +$4.39K
ASAN icon
608
Asana
ASAN
$2.28B
$27K 0.01%
+2,047
New +$28.9K
M icon
609
Macy's
M
$6.27B
$27K 0.01%
1,514
-1,991
-57% -$28.2K
SAP icon
610
SAP
SAP
$242B
$27K 0.01%
102
-4,898
-98% -$1.38M
MBX
611
MBX Biosciences
MBX
$3.23B
$27K 0.01%
+1,575
New +$21.1K
KAPA
612
Kairos Pharma
KAPA
$7.71M
$27K 0.01%
+23,500
New +$26.9K
ACHR icon
613
Archer Aviation
ACHR
$5.37B
$26K 0.01%
2,729
-3,153
-54% -$31.2K
AMPH icon
614
Amphastar Pharmaceuticals
AMPH
$858M
$26K 0.01%
+1,000
New +$25.8K
BBBY
615
Bed Bath & Beyond
BBBY
$423M
$26K 0.01%
3,002
-3,615
-55% -$29.9K
MDT icon
616
Medtronic
MDT
$116B
$26K 0.01%
277
-4,023
-94% -$370K
MSFT icon
617
CALL
Microsoft
MSFT
$3.69T
$26K 0.01%
+51
New +$26K
NTRS icon
618
Northern Trust
NTRS
$34.8B
$26K 0.01%
200
– –
PAR icon
619
PAR Technology
PAR
$770M
$26K 0.01%
+682
New +$37.7K
PATH icon
620
UiPath
PATH
$8.64B
$26K 0.01%
+2,000
New +$23.6K
STLA icon
621
Stellantis
STLA
$20.2B
$26K 0.01%
2,800
– –
MPVD
622
DELISTED
Mountain Province Diamonds Inc.
MPVD
$26K 0.01%
952,750
– –
CSX icon
623
CSX Corp
CSX
$92.9B
$25K 0.01%
720
+586
+437% +$20K
ENVX icon
624
CALL
Enovix
ENVX
$966M
$25K 0.01%
2,568
-1,149
-31% -$12.7K
GT icon
625
Goodyear
GT
$1.78B
$25K 0.01%
3,412
+404
+13% +$3.8K
23 24
25
26 27

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.